Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213

Clinical trial NCT05305989 · COMPLETED

Trial details

NCT number: NCT05305989
Sponsor: Kadmon, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft-versus-host-disease

Start date: 2022-02-23
Primary completion: 2024-06-06
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.